Approved by the FDA February 11, 2011, breast tomosynthesis, a new imaging technology pioneered by the MGH Breast Imaging Program under the leadership of Elizabeth Rafferty, MD, director of Breast Imaging at MGH, produces a 3D image of the breast and gives doctors a clearer view through the overlapping structures of breast tissue.
